245 related articles for article (PubMed ID: 18171910)
1. Development of hyperinsulinemia and insulin resistance during the early stage of weight gain.
Erdmann J; Kallabis B; Oppel U; Sypchenko O; Wagenpfeil S; Schusdziarra V
Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E568-75. PubMed ID: 18171910
[TBL] [Abstract][Full Text] [Related]
2. Weight-dependent differential contribution of insulin secretion and clearance to hyperinsulinemia of obesity.
Erdmann J; Mayr M; Oppel U; Sypchenko O; Wagenpfeil S; Schusdziarra V
Regul Pept; 2009 Jan; 152(1-3):1-7. PubMed ID: 19026695
[TBL] [Abstract][Full Text] [Related]
3. Reduction in peripheral vascular resistance predicts improvement in insulin clearance following weight loss.
Straznicky NE; Grima MT; Sari CI; Lambert EA; Phillips SE; Eikelis N; Kobayashi D; Hering D; Mariani JA; Dixon JB; Nestel PJ; Karapanagiotidis S; Schlaich MP; Lambert GW
Cardiovasc Diabetol; 2015 Aug; 14():113. PubMed ID: 26297500
[TBL] [Abstract][Full Text] [Related]
4. Insulin action and secretion in healthy, glucose tolerant first degree relatives of patients with type 2 diabetes mellitus. Influence of body weight.
Volk A; Renn W; Overkamp D; Mehnert B; Maerker E; Jacob S; Balletshofer B; Häring HU; Rett K
Exp Clin Endocrinol Diabetes; 1999; 107(2):140-7. PubMed ID: 10320055
[TBL] [Abstract][Full Text] [Related]
5. Fat mass largely contributes to insulin mediated glucose uptake in morbidly obese subjects.
Gniuli D; Castagneto-Gissey G; Iaconelli A; Leccesi L; Mingrone G
Int J Obes (Lond); 2010 Dec; 34(12):1726-32. PubMed ID: 20498658
[TBL] [Abstract][Full Text] [Related]
6. Acute postchallenge hyperinsulinemia predicts weight gain: a prospective study.
Sigal RJ; El-Hashimy M; Martin BC; Soeldner JS; Krolewski AS; Warram JH
Diabetes; 1997 Jun; 46(6):1025-9. PubMed ID: 9166675
[TBL] [Abstract][Full Text] [Related]
7. Lack of insulin inhibition on insulin secretion in non-diabetic morbidly obese patients.
Muscelli E; Pereira JA; Lazarin MA; da Silva CA; Pareja JC; Saad MJ
Int J Obes Relat Metab Disord; 2001 Jun; 25(6):798-804. PubMed ID: 11439292
[TBL] [Abstract][Full Text] [Related]
8. Defects in beta-cell function in functional ovarian hyperandrogenism.
O'Meara NM; Blackman JD; Ehrmann DA; Barnes RB; Jaspan JB; Rosenfield RL; Polonsky KS
J Clin Endocrinol Metab; 1993 May; 76(5):1241-7. PubMed ID: 8496316
[TBL] [Abstract][Full Text] [Related]
9. Effects of gastric bypass surgery on insulin resistance and insulin secretion in nondiabetic obese patients.
Promintzer-Schifferl M; Prager G; Anderwald C; Mandl M; Esterbauer H; Shakeri-Leidenmühler S; Pacini G; Stadler M; Bischof MG; Ludvik B; Luger A; Krebs M
Obesity (Silver Spring); 2011 Jul; 19(7):1420-6. PubMed ID: 21494227
[TBL] [Abstract][Full Text] [Related]
10. Reduction of insulin clearance during hyperglycemic clamp. Dose-response study in normal humans.
Tillil H; Shapiro ET; Rubenstein AH; Galloway JA; Polonsky KS
Diabetes; 1988 Oct; 37(10):1351-7. PubMed ID: 3046967
[TBL] [Abstract][Full Text] [Related]
11. Acute elevation of NEFA causes hyperinsulinemia without effect on insulin secretion rate in healthy human subjects.
Balent B; Goswami G; Goodloe G; Rogatsky E; Rauta O; Nezami R; Mints L; Angeletti RH; Stein DT
Ann N Y Acad Sci; 2002 Jun; 967():535-43. PubMed ID: 12079885
[TBL] [Abstract][Full Text] [Related]
12. Hyperinsulinemia in nonobese women reporting a moderate weight gain at the beginning of menopause: a useful early measure of susceptibility to insulin resistance.
Lemay A; Turcot L; Déchêne F; Dodin S; Forest JC
Menopause; 2010 Mar; 17(2):321-5. PubMed ID: 19745772
[TBL] [Abstract][Full Text] [Related]
13. Reduced insulin secretion: an independent predictor of body weight gain.
Schwartz MW; Boyko EJ; Kahn SE; Ravussin E; Bogardus C
J Clin Endocrinol Metab; 1995 May; 80(5):1571-6. PubMed ID: 7745002
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal changes in pancreatic beta-cell function and metabolic clearance rate of insulin in pregnant women with normal and abnormal glucose tolerance.
Catalano PM; Drago NM; Amini SB
Diabetes Care; 1998 Mar; 21(3):403-8. PubMed ID: 9540023
[TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone reduces glucose-stimulated insulin secretion rate and increases insulin clearance in nondiabetic, insulin-resistant individuals.
Kim SH; Abbasi F; Chu JW; McLaughlin TL; Lamendola C; Polonsky KS; Reaven GM
Diabetes; 2005 Aug; 54(8):2447-52. PubMed ID: 16046313
[TBL] [Abstract][Full Text] [Related]
16. [Insulin resistance and insulin secretion in type II non-obese diabetics].
Pelikánová T; Válek J; Kazdová L; Saudek F; Karasová L
Cas Lek Cesk; 1994 Mar; 133(6):172-6. PubMed ID: 8156572
[TBL] [Abstract][Full Text] [Related]
17. Rats with portal-caval vein transposition show hyperinsulinemia and insulin resistance.
Williamson MP; Behme MT; Dupré J; Grant DR; Guan J; Zhong R
Metabolism; 1996 Jan; 45(1):120-5. PubMed ID: 8544769
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the kinetics of C-peptide and insulin secretion in hyperthyroidism.
O'Meara NM; Blackman JD; Sturis J; Polonsky KS
J Clin Endocrinol Metab; 1993 Jan; 76(1):79-84. PubMed ID: 8421108
[TBL] [Abstract][Full Text] [Related]
19. Insulin sensitivity and secretion in normal children related to size at birth, postnatal growth, and plasma insulin-like growth factor-I levels.
Ong KK; Petry CJ; Emmett PM; Sandhu MS; Kiess W; Hales CN; Ness AR; Dunger DB;
Diabetologia; 2004 Jun; 47(6):1064-70. PubMed ID: 15156313
[TBL] [Abstract][Full Text] [Related]
20. Suppression of Endogenous Insulin Secretion by Euglycemic Hyperinsulinemia.
Karakaplan ND; Song Y; Laurenti MC; Vella A; Jensen MD
J Clin Endocrinol Metab; 2024 Jan; 109(2):e596-e601. PubMed ID: 37758511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
